Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
Scandinavian Journal of Gastroenterology, 06/22/09
Haukeland JW et al. - Treatment with metformin for 6 months was no better than placebo in terms of improvement in liver histology in patients with NAFLD. Nevertheless, the use of metformin could still be beneficial in this group as it is associated with a reduction in serum levels of lipids and glucose.
Related Articles
Non-alcoholic fatty liver disease from pathogenesis to management: an update
Obesity Reviews, 11/02/09
Relevance Score: 91%%
Non-alcoholic fatty liver disease from pathogenesis to management: an update
Obesity Reviews, 10/30/09
Relevance Score: 91%%
Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system
Journal of Hepato-Biliary-Pancreatic Surgery, 10/09/09
Relevance Score: 91%%
Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis
World Journal of Gastroenterology, 10/01/09
Relevance Score: 85%%
Activation of the complement system in human nonalcoholic fatty liver disease
Hepatology, 10/13/09
Relevance Score: 84%%
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Angiogenesis Soluble Factors as Hepatocellular Carcinoma Noninvasive Markers for Monitoring Hepatitis C Virus Cirrhotic Patients Awaiting Liver Transplantation
Transplantation, 11/25/09
Effects of Prophylactic Splenic Artery Modulation on Portal Overperfusion and Liver Regeneration in Small-for-Size Graft
Transplantation, 11/25/09
Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma
Journal of Surgical Oncology, 11/25/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of a Solitary Bone Metastasis to the Tibia from Colorectal Cancer
Case Reports in Gastroenterology, 11/25/09
Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09
Adult Cyclic Vomiting Syndrome Successfully Treated with Intranasal Sumatriptan
Journal of General Internal Medicine, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


